VIV-HF: Virtual Visits in Heart Failure Care Transitions

Sponsor
The Cleveland Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT03675828
Collaborator
(none)
116
1
2
12.7
9.1

Study Details

Study Description

Brief Summary

This study evaluates the use of virtual visits in the post-discharge care of patients with heart failure. Participants admitted to the hospital with a primary diagnosis of heart failure will be randomized at discharge to either a virtual visit or outpatient visit for their 7-day post discharge follow up visit.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Virtual Visit
N/A

Detailed Description

Published guidelines recommend that patients being discharged home after hospitalization for HF should be offered a 7-day post-discharge outpatient clinic visit as a way to increase engagement with care and reduce risk of poor outcomes. Unfortunately no-show rates for the 7-day post-discharge outpatient visit in this population are high, suggesting poor engagement. The investigators have previously observed a 76% no-show rate at the Cleveland Clinic Main Campus. This study is to evaluate whether use of 7-day post-discharge virtual visit versus in-person visit can improve adherence with post-discharge appointment.

Study Design

Study Type:
Interventional
Actual Enrollment :
116 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Virtual Visits in Heart Failure Care Transitions
Actual Study Start Date :
Aug 7, 2018
Actual Primary Completion Date :
Aug 28, 2019
Actual Study Completion Date :
Aug 28, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual Visit

In this arm, the 7-day post discharge visit will be completed by a scheduled virtual visit with a member of the study team using the Cleveland Clinic Online Express Care application on a computer or a tablet/phone.

Behavioral: Virtual Visit
The Cleveland Clinic Express Care Online application will be used in this intervention. The subjects will have a virtual consult with a clinician from the study team that will mirror an experience had at an outpatient post-discharge visit, including review of systems and medications.

No Intervention: Outpatient Clinic

In this arm, the 7-day post discharge visit will be completed by a standard-of-care, in-person outpatient visit with a member of the study team in the heart failure clinic.

Outcome Measures

Primary Outcome Measures

  1. Proportion of completed post discharge visits via virtual visit or in outpatient setting [12 months]

    Proportion of patients who complete 7-day post discharge appointment (virtually or in-person)

Secondary Outcome Measures

  1. 45-day unplanned readmission and death measures stratified by visit method (virtually or in-person) [12 months]

    Composite and individual components of unscheduled all-cause first occurrence of (a.) hospital readmission, (b.) emergency department visit, or (c.) death, in the first 45 days after hospital discharge.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Hospitalized for primary diagnosis of HF;

  2. Anticipated to be discharged home;

  3. Agreeable to longitudinal post-discharge care at Cleveland Clinic Main Campus in the first few weeks after hospital discharge;

  4. Patient or an individual in their social support network has the ability (equipment and connectivity) to do a virtual visit after hospital discharge;

Exclusion Criteria:
  1. Being transferred to another hospital, or being discharged to an inpatient facility or nursing home;

  2. Being discharged to hospice;

  3. Subject currently enrolled in an interventional research study that requires an in-person clinical visit within 7 days post-discharge.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cleveland Clinic Cleveland Ohio United States 44195

Sponsors and Collaborators

  • The Cleveland Clinic

Investigators

  • Principal Investigator: Wai Hong Wilson Tang, MD, The Cleveland Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wilson Tang, Principal Investigator, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT03675828
Other Study ID Numbers:
  • 18-651
First Posted:
Sep 18, 2018
Last Update Posted:
Sep 25, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wilson Tang, Principal Investigator, The Cleveland Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 25, 2019